Literature DB >> 22300284

Serum leptin, adiponectin, resistin and ghrelin levels in psoriatic patients treated with cyclosporin.

Mustafa Ozdemir1, Mavişe Yüksel, Hakkı Gökbel, Nilsel Okudan, Inci Mevlitoğlu.   

Abstract

Cyclosporin has various effects on adipose tissue and glucose metabolism. This situation may lead to changes in serum levels of adipocyte-derived cytokines which have influence on the pathogenesis of psoriasis. The aim of this study was to evaluate the effect of cyclosporin treatment on some adipocyte-derived cytokines in psoriatic patients. This case-control study was performed between June 2009 and March 2010, at the Department of Dermatology of Meram School of Medicine. Serum leptin, adiponectin, resistin and ghrelin levels were assessed in 26 patients with psoriasis before and after cyclosporin treatment and body mass index-matched 26 healthy control subjects. The adipokines levels were compared between the groups. Serum leptin, ghrelin, resistin and adiponectin levels in patients with psoriasis before the treatment were higher than those of the control group but the differences were not statistically significant. A positive correlation between serum leptin and family history of psoriasis was detected (r = 0.398, P = 0.044). A strong negative correlation between the Psoriasis Area and Severity Index and serum ghrelin levels was seen (r = -0.52, P = 0.001) and there was a strong positive correlation between the Nail Psoriasis Severity Index and serum resistin levels (r = 0.62, P = 0.001). Following the treatment, a significant increase was seen in the serum level of adiponectin (P = 0.02) and resistin (P = 0.003). The correlations between the adipokines and the disease parameters before the treatment were lost after the treatment. Our results suggest that levels of some adipocyte-derived cytokines in psoriatic patients are affected by cyclosporin treatment.
© 2012 Japanese Dermatological Association.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22300284     DOI: 10.1111/j.1346-8138.2011.01497.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  12 in total

Review 1.  Non-alcoholic fatty liver disease and psoriasis: So far, so near.

Authors:  Giulia Ganzetti; Anna Campanati; Annamaria Offidani
Journal:  World J Hepatol       Date:  2015-03-27

Review 2.  Adiponectin in inflammatory and immune-mediated diseases.

Authors:  Giamila Fantuzzi
Journal:  Cytokine       Date:  2013-07-11       Impact factor: 3.861

3.  Increased serum resistin levels correlate with psoriasis: a meta-analysis.

Authors:  Huiyun Huang; Erdong Shen; Shiqing Tang; Xingyou Tan; Xiuli Guo; Qiang Wang; Hongwei Ding
Journal:  Lipids Health Dis       Date:  2015-05-16       Impact factor: 3.876

4.  Selected Inflammatory and Metabolic Markers in Psoriatic Patients Treated with Goeckerman Therapy.

Authors:  Katerina Kondelkova; Lenka Borska; Ctirad Andrys; Jan Krejsek; Kvetoslava Hamakova; Simona Rendarova; Vit Rehacek; Jan Kremlacek; Zdenek Fiala
Journal:  Mediators Inflamm       Date:  2015-06-08       Impact factor: 4.711

5.  Assessment of Leptin Gene Polymorphism rs2060713 in Psoriasis Vulgaris.

Authors:  Anthony Karpouzis; Gregory Tripsianis; Elisavet Gatzidou; Stavroula Veletza
Journal:  ISRN Dermatol       Date:  2014-01-28

6.  Metabolic changes and serum ghrelin level in patients with psoriasis.

Authors:  Haydar Ucak; Betul Demir; Demet Cicek; Ilker Erden; Suleyman Aydin; Selma Bakar Dertlioglu; Mustafa Arica
Journal:  Dermatol Res Pract       Date:  2014-12-18

7.  Effect of psoriasis activity on serum adiponectin and leptin levels.

Authors:  Anna Baran; Iwona Flisiak; Jerzy Jaroszewicz; Magdalena Świderska
Journal:  Postepy Dermatol Alergol       Date:  2015-03-30       Impact factor: 1.837

8.  Serum ghrelin levels in patients with Behcet's disease.

Authors:  Ilker Erden; Haydar Uçak; Betül Demir; Demet Cicek; Selma Bakar Dertlioğlu; Suleyman Aydin; Savas Ozturk
Journal:  Postepy Dermatol Alergol       Date:  2016-12-02       Impact factor: 1.837

9.  Metabolic Syndrome and Selective Inflammatory Markers in Psoriatic Patients.

Authors:  Simona Vachatova; Ctirad Andrys; Jan Krejsek; Miloslav Salavec; Karel Ettler; Vit Rehacek; Eva Cermakova; Andrea Malkova; Zdenek Fiala; Lenka Borska
Journal:  J Immunol Res       Date:  2016-12-21       Impact factor: 4.818

10.  Psoriasis in obesity: comparison of serum levels of leptin and adiponectin in obese subjects - cases and controls.

Authors:  Nádia Couto Bavoso; Jackson Machado Pinto; Maria Marta Sarquis Soares; Michelle Dos Santos Diniz; Antônio Lúcio Teixeira Júnior
Journal:  An Bras Dermatol       Date:  2019-05-09       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.